08:00 , Jan 12, 2015 |  BC Week In Review  |  Financial News

Clementia financial update

Clementia Pharmaceuticals Inc. , Dorval, Quebec   Business: Musculoskeletal   Date announced: 2015-01-05   Note: Clementia raised $10 million in an extension of a series A round, bringing the total raised to $32.5 million. OrbiMed...
07:00 , Sep 25, 2014 |  BC Innovations  |  Strategy

Canadian accelerant

After seven years of building bridges between the Canadian research and business communities through technology transfer consortia, the government's Centres of Excellence for Commercialization and Research program has launched the country's first national health science...
07:00 , Sep 22, 2014 |  BC Week In Review  |  Company News

Accel-Rx Health Sciences Accelerator finance news

Accel-Rx, a pan-Canadian health sciences accelerator, announced its official launch after receiving a C$14.5 million ($13.1 million) award from the Canadian government's Centers of Excellence for Commercialization and Research (CECR) program. CDRD Ventures Inc. ,...
08:00 , Jan 13, 2014 |  BC Week In Review  |  Financial News

Clementia completes venture financing

Clementia Pharmaceuticals Inc. , Dorval, Quebec   Business: Musculoskeletal   Date completed: 1/9/14   Type: Venture financing   Raised: $22.5 million   Investors: OrbiMed Advisors; BDC Venture Capital  ...
01:59 , Jan 10, 2014 |  BC Extra  |  Financial News

Clementia raises $22.5 million in A round

Clementia Pharmaceuticals Inc. (Dorval, Quebec) raised $22.5 million in a series A round led by new investor OrbiMed Advisors, with participation from existing investor BDC Venture Capital. Clementia is planning a Phase II trial for...
07:00 , Sep 30, 2013 |  BioCentury  |  Finance

Broader minded in Canada

Broader minded in Canada With C$135 million ($131 million) for its second healthcare fund, the venture arm of the Business Development Bank of Canada is hoping to achieve top quartile returns so that when BDC...
07:00 , Sep 23, 2013 |  BC Week In Review  |  Financial News

BDC Venture Capital financial update

The Business Development Bank of Canada (BDC) has allocated C$135 million ($131 million) to its BDC Venture Capital venture arm for a new healthcare fund. The BDC Venture Capital Healthcare Fund will invest in Canadian...
07:00 , Sep 23, 2013 |  BioCentury  |  Finance

Quebec engine

Quebec engine Drawn by an experienced management team and the low cost of doing business in Montreal, Sanderling Ventures launched Therillia Development Co. Inc. to manage early stage development of assets to be funded by...
01:29 , Sep 19, 2013 |  BC Extra  |  Financial News

BDC Venture Capital receives C$135M for new healthcare fund

The Business Development Bank of Canada (BDC) has allocated C$135 million ($131 million) to its BDC Venture Capital venture arm for a new healthcare fund. The BDC Venture Capital Healthcare Fund will invest in Canadian...
07:00 , Sep 9, 2013 |  BC Week In Review  |  Financial News

Sanderling Ventures financial update

Sanderling Ventures secured $30 million from BDC Venture Capital and Fonds de solidarite FTQ for a Canadian fund that Sanderling said will operate in parallel to its Sanderling VII fund, which is targeting $250 million....